| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:118.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Department of Medicine, University of Florida, Gainesville (Y.S., L.W., J.C.S.), and CV Therapeutics, Palo Alto, Calif (L.B.).
Correspondence to Yejia Song, PO Box 100277, Department of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610. E-mailsongy{at}medicine.ufl.edu
Background The goal of this study was to examine the hypothesis that a partial agonist of the adenosine A1 receptor (A1AdoR) may cause a greater attenuation of catecholamine-induced ventricular arrhythmic activity than of contractility.
Methods and Results The effects of CVT-2759 and adenosine, a partial and a full agonist of the A1AdoR, on isoproterenol-stimulated arrhythmic activity and contractility of guinea pig isolated ventricular myocytes were determined. CVT-2759 (10 µmol/L) and adenosine (10 µmol/L) significantly inhibited isoproterenol-induced arrhythmic activity (aftercontraction and transient inward current) but did not reduce the amplitudes of twitch shortening and L-type Ca2+ current. Increasing the concentration of the full agonist adenosine from 10 to 100 µmol/L, however, caused significant attenuation of twitch shortening as well as aftercontractions, whereas increasing the concentration of the partial agonist CVT-2759 from 10 to 100 µmol/L did not. CVT-2759 also significantly inhibited isoproterenol-induced spontaneous ventricular beats in isolated hearts. In contrast to adenosine, CVT-2759 neither activated adenosine-sensitive K+ current nor shortened the duration of the atrial APD.
Conclusions The present results support the hypothesis and suggest a potential role for a partial agonist of the A1AdoR in the treatment of cardiac arrhythmias.
Key Words: adenosine arrhythmia contractility myocytes
This article has been cited by other articles:
![]() |
P. Bartholoma, E. Gorjup, D. Monz, A. Reininger-Mack, H. Thielecke, and A. Robitzki Three-Dimensional In Vitro Reaggregates of Embryonic Cardiomyocytes: A Potential Model System for Monitoring Effects of Bioactive Agents J Biomol Screen, December 1, 2005; 10(8): 814 - 822. [Abstract] [PDF] |
||||
![]() |
L. Fabritz, P. Kirchhof, L. Fortmuller, J. A Auchampach, H. A Baba, G. Breithardt, J. Neumann, P. Boknik, and W. Schmitz Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A3 adenosine receptors Cardiovasc Res, June 1, 2004; 62(3): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, L. Fabritz, L. Fortmuller, G. P. Matherne, A. Lankford, H. A. Baba, W. Schmitz, G. Breithardt, J. Neumann, and P. Boknik Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H145 - H153. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |